Mohammad S. Rostami

Array ( [id] => 5802292 [patent_doc_number] => 20020010201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Method for treating restless leg syndrome using pramipexole and clonidine' [patent_app_type] => new [patent_app_number] => 09/970839 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2583 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010201.pdf [firstpage_image] =>[orig_patent_app_number] => 09970839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363147 [patent_doc_number] => 06569841 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Ion exchange tumor targeting (IETT)' [patent_app_type] => B1 [patent_app_number] => 09/807542 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2026 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569841.pdf [firstpage_image] =>[orig_patent_app_number] => 09807542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6209904 [patent_doc_number] => 20020072485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists' [patent_app_type] => new [patent_app_number] => 09/969354 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11610 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072485.pdf [firstpage_image] =>[orig_patent_app_number] => 09969354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433063 [patent_doc_number] => 20040162312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'NMDA NR2B antagonists for treatment' [patent_app_type] => new [patent_app_number] => 09/969318 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9821 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162312.pdf [firstpage_image] =>[orig_patent_app_number] => 09969318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440336 [patent_doc_number] => 20020128304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Use of melanin for inhibition of angiogenesis and macular degeneration' [patent_app_type] => new [patent_app_number] => 09/966282 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128304.pdf [firstpage_image] =>[orig_patent_app_number] => 09966282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440422 [patent_doc_number] => 06495588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Scytonemin and methods of using thereof' [patent_app_type] => B2 [patent_app_number] => 09/960314 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 18044 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495588.pdf [firstpage_image] =>[orig_patent_app_number] => 09960314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418289 [patent_doc_number] => 06509367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Pyrazole cannabinoid agonist and antagonists' [patent_app_type] => B1 [patent_app_number] => 09/682577 [patent_app_country] => US [patent_app_date] => 2001-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15980 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509367.pdf [firstpage_image] =>[orig_patent_app_number] => 09682577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625755 [patent_doc_number] => 20020016367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Nonpeptide insulin receptor agonists' [patent_app_type] => new [patent_app_number] => 09/961179 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5800 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016367.pdf [firstpage_image] =>[orig_patent_app_number] => 09961179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243267 [patent_doc_number] => 20020045656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Pharmaceutical combinations for the treatment of stroke and traumatic brain injury' [patent_app_type] => new [patent_app_number] => 09/947652 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16393 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045656.pdf [firstpage_image] =>[orig_patent_app_number] => 09947652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291909 [patent_doc_number] => 20020055533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 09/943712 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4611 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055533.pdf [firstpage_image] =>[orig_patent_app_number] => 09943712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156938 [patent_doc_number] => 06762182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-13 [patent_title] => 'Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/869384 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16903 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762182.pdf [firstpage_image] =>[orig_patent_app_number] => 09869384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987506 [patent_doc_number] => 20020099059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Combination therapy for the treatment of migraine' [patent_app_type] => new [patent_app_number] => 09/934276 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2869 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099059.pdf [firstpage_image] =>[orig_patent_app_number] => 09934276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889344 [patent_doc_number] => 20020013367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Antiproliferative and neurotrophic molecules' [patent_app_type] => new [patent_app_number] => 09/929810 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12012 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013367.pdf [firstpage_image] =>[orig_patent_app_number] => 09929810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243316 [patent_doc_number] => 20020045669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Anti-arrhythmic composition and methods of treatment' [patent_app_type] => new [patent_app_number] => 09/925511 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4994 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045669.pdf [firstpage_image] =>[orig_patent_app_number] => 09925511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363546 [patent_doc_number] => 06569866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-27 [patent_title] => 'Sustained-release nalmefene preparations and method' [patent_app_type] => B2 [patent_app_number] => 09/922873 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6937 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569866.pdf [firstpage_image] =>[orig_patent_app_number] => 09922873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142261 [patent_doc_number] => 20020002181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Use of leptin antagonists for the treatment of diabetes' [patent_app_type] => new [patent_app_number] => 09/922675 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2813 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002181.pdf [firstpage_image] =>[orig_patent_app_number] => 09922675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080786 [patent_doc_number] => 06835742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release' [patent_app_type] => B2 [patent_app_number] => 09/921479 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4793 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835742.pdf [firstpage_image] =>[orig_patent_app_number] => 09921479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859933 [patent_doc_number] => 20020123513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Use of glycogen phosphorylase inhibitors to inhibit tumor growth' [patent_app_type] => new [patent_app_number] => 09/919205 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17161 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123513.pdf [firstpage_image] =>[orig_patent_app_number] => 09919205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601921 [patent_doc_number] => 06432384 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Breathing gas mixture containing perfluorocarbons' [patent_app_type] => B1 [patent_app_number] => 09/912087 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1771 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432384.pdf [firstpage_image] =>[orig_patent_app_number] => 09912087 [rel_patent_id] =>[rel_patent_doc_number] =>)